PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
11.43%
Some net income increase while CRON.TO is negative at -277.16%. John Neff would see a short-term edge over the struggling competitor.
11.97%
D&A growth well above CRON.TO's 1.28%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
No Data
No Data available this quarter, please select a different quarter.
346.29%
SBC growth of 346.29% while CRON.TO is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-4008.66%
Both reduce yoy usage, with CRON.TO at -98.32%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-185.95%
AR is negative yoy while CRON.TO is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-51723.06%
Negative yoy inventory while CRON.TO is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
100.00%
A yoy AP increase while CRON.TO is negative at -71.27%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
117.15%
Some yoy usage while CRON.TO is negative at -77.75%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
187.28%
Lower 'other non-cash' growth vs. CRON.TO's 8800.77%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
48.20%
Some CFO growth while CRON.TO is negative at -47.06%. John Neff would note a short-term liquidity lead over the competitor.
-5.66%
Negative yoy CapEx while CRON.TO is 83.18%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
93.95%
Growth of 93.95% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
-2.87%
We reduce yoy invests while CRON.TO stands at 86.80%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.